Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions

被引:1
|
作者
Farghaly, Hussein [1 ,2 ]
Alshareef, Mohamed [2 ]
Alqarni, Abdullah [2 ]
Sayed, Mohamed [1 ]
Nasr, Hatem [2 ,3 ]
机构
[1] Assiut Univ, Fac Med, Dept Oncol & Nucl Med, Assiut, Egypt
[2] Prince Sultan Mil Med City, Dept Radiol, Riyadh, Saudi Arabia
[3] Cairo Univ, Fac Med, Dept Oncol & Nucl Med, Cairo, Egypt
关键词
18F]Flurodeoxyglucose positron emission tomography/Computed tomography (F-18 FDG PET/CT); Dual time point imaging; Gastric malignancy; Water gastric distension; F-18-FDG PET; ORAL CONTRAST; FOLLOW-UP; CANCER; DIAGNOSIS; STOMACH; PITFALLS; EXPRESSION; CARCINOMA; TUMOR;
D O I
10.1016/j.ejro.2020.100268
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To assess diagnostic accuracy and added value of dual time point F-18-FDG PET/CT after gastric distention using oral water in differentiating malignant from benign gastric lesions. Methods: Patients (n = 30, 19 males, mean age 58.6 +/- 16.4 years). All patients are known or suspected oncology patients. All patients underwent whole body F-18-FDG PET/CT scan and 2 h delayed PET/CT abdominal images following oral water gastric distension. The best cut off values for early SUVmax (SUVmax1), delayed SUVmax (SUVmax2) and SUVmax2-SUVmax1 (Delta SUVmax) to differentiate benign from malignant lesions were set based on ROC analysis. Data analyzed included in addition; age, sex and F-18-FDG uptake pattern in delayed images. Suspicious gastric lesions were correlated with biopsy in 18 patients (60 %) and with clinical and follow-up imaging (F-18-FDG PET/CT, CT or MRI) in 12 patients (40 %). Unpaired t-test was used to compare the mean deference in continuous variables between patients with gastric malignancy and those with benign gastric lesions. Fisher's exact test was used to analyze categorical variables. Logistic regression analysis was performed to identify the most powerful factors to predict malignant lesions. Results: Fifteen patients (50 %) had confirmed malignant gastric lesions. Patients with confirmed gastric malignancy were older (65 +/- 13 vs 52 +/- 17; p = 0.023) and had significantly higher mean Delta SUVmax (1.29 +/- 1.76 vs 0.89 +/- 1.59; p = 0.003). The mean SUVmax1 (6.99 +/- 6.66 vs 5.31 +/- 2.53; p = 0.367) and SUVmax2 (8.29 +/- 7.41 vs 4.44 +/- 3.34; p = 0.077) although both higher in patients with malignant lesions, they did not reach statistical significance. Sensitivity, specificity, PPV, NPV, and accuracy to detect malignant gastric lesions were highest for lesions with localized uptake pattern in delayed images post water oral contrast as well as for lesions with Delta SUVmax>0. Regression analysis revealed both variables as independent predictors for malignant lesions with odd ratios of 22.9 and 9.5 respectively and final model Chi-Square of 19.9 (p < 0.0001). The model correctly identified 12/15 (80 %) malignant lesions and 13/15 (86.7 %) benign lesions with 2 false positives confirmed as chronic active gastritis with helicobacter pylori and 3 false negatives including 1 signet ring gastric cancer and 1 low grade gastrointestinal stromal tumor (GIST), both with poor 18 F-FDG uptake. Conclusion: Localized uptake pattern in delayed PET/CT images following gastric distention with oral water contrast as well as Delta SUVmax>0 are powerful independent variables to identify malignant gastric lesions with fairly high sensitivity and reasonable accuracy. Malignancies with inherently low F-18-FDG avidity are the main cause of false negatives while active gastritis is the main cause of false positives.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors
    Takashi Matsumoto
    Hirohisa Okabe
    Yo-ichi Yamashita
    Toshihiko Yusa
    Rumi Itoyama
    Yosuke Nakao
    Takanobu Yamao
    Naoki Umzaki
    Masayo Tsukamoto
    Yuki Kitano
    Tatsunori Miyata
    Kota Arima
    Hidetoshi Nitta
    Hiromitsu Hayashi
    Katsunori Imai
    Akira Chikamoto
    Hideo Baba
    Surgery Today, 2019, 49 : 21 - 26
  • [22] Dual-Tracer Positron Emission Tomography/Computed Tomography with [18F]FDG and [18F]fluorocholine in a Patient with Metastatic Parathyroid Carcinoma
    Iacovitti, Cesare Michele
    Cuzzocrea, Marco
    Gianola, Lauro
    Paone, Gaetano
    Treglia, Giorgio
    DIAGNOSTICS, 2024, 14 (14)
  • [23] IMPACT OF DUAL TIME POINT IMAGING OF 18-FDG PET/CT IN DIFFERENTIATION BETWEEN MALIGNANT AND BENIGN HEPATIC LESIONS
    Alqarni, A.
    Farghaly, H.
    Nasr, H.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 20 - 20
  • [24] Dual time point [18F]FDG PET/CT for differentiating benign from malignant musculoskeletal tumors
    D'Abadie, P.
    Gheysens, O.
    Lhommel, R.
    De Roo, A.
    Schubert, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S111 - S111
  • [25] [18F] Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy
    Hildebrandt, Malene Grubbe
    Gerke, Oke
    Baun, Christina
    Falch, Kirsten
    Hansen, Jeanette Ansholm
    Farahani, Ziba Ahangarani
    Petersen, Henrik
    Larsen, Lisbet Bronsro
    Duvnjak, Sandra
    Buskevica, Inguna
    Bektas, Selma
    Soe, Katrine
    Jylling, Anne Marie Bak
    Ewertz, Marianne
    Alavi, Abass
    Hoilund-Carlsen, Poul Flemming
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (16) : 1889 - +
  • [26] [18F]fluorocholine positron emission tomography/ computed tomography characterization of benign thyroid nodules
    Studen, K. Bajuk
    Rep, S.
    Gaberscek, S.
    Zaletel, K.
    Armic, E. Skorjanec
    Lezaic, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S630 - S631
  • [27] 18F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma
    Li, Xiao-Feng
    Fu, Qiang
    Dong, You-Wen
    Liu, Jian-Jing
    Song, Xiu-Yu
    Dai, Dong
    Zuo, Cong
    Xu, Wen-Gui
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (34) : 7787 - 7796
  • [28] 18F-Fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma
    Xiao-Feng Li
    Qiang Fu
    You-Wen Dong
    Jian-Jing Liu
    Xiu-Yu Song
    Dong Dai
    Cong Zuo
    Wen-Gui Xu
    World Journal of Gastroenterology, 2016, (34) : 7787 - 7796
  • [29] A Patient with a Benign and a Malignant Primary Pulmonary Meningioma: An Evaluation with 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Computed Tomography with Iodinated Contrast
    Cimini, Andrea
    Ricci, Francesca
    Pugliese, Luca
    Chiaravalloti, Agostino
    Schillaci, Orazio
    Floris, Roberto
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2019, 34 (01): : 45 - 47
  • [30] Differentiation of malignant from benign heart and pericardial lesions using positron emission tomography and computed tomography
    Shao, Dan
    Wang, Shu-Xia
    Liang, Chang-Hong
    Gao, Qiang
    JOURNAL OF NUCLEAR CARDIOLOGY, 2011, 18 (04) : 668 - 677